Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 9, 2009

Pfizer and Crown Team Up to Develop Treatments for Asian Cancers

  • Pfizer is partnering with oncology services company Crown Bioscience to develop novel therapeutics for cancers prevalent in Asia. The joint research will be carried out at Crown’s new facility near Shanghai and aims to discover and advance multiple candidates for clinical development.

    Crown will receive an upfront payment and research funding under the terms of the deal with Pfizer. It is also eligible to preclinical and development milestones as products progress.

    Based in California, Crown operates wholly owned research facilities at campuses in Beijing and Taicang, China, and in Indianapolis. The company claims its CrystalClear™ and HuPrime™ platforms provide unique capabilities in lead optimization and translational oncology for the development of clinical candidates.

     



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »